Inhibition of DNA synthesis by aspirin in Swiss 3T3 fibroblasts

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 1, 1997, Pages 366-372

  Castaño, Esther ^a   Dalmau, Mireia ^a   Martí, Mercè ^b   Berrocal, Félix ^b   Bartrons, Ramon ^a   Gil, Joan ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Division Consumer Care   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BOMBESIN; CYCLIC AMP; DNA; EPIDERMAL GROWTH FACTOR; FORSKOLIN; INSULIN; ISOBUTYLMETHYLXANTHINE; PLATELET DERIVED GROWTH FACTOR; PROSTAGLANDIN E2; PROTEIN KINASE C;

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; COLON CANCER; COLON CARCINOGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; DRUG EFFECT; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS;

EID: 0030893314     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. ALBERTS, D. S., HIXSON, L., AHNEN, D., BOGERT, C., EINSPAHR, J., PARANKA, N., BRENDEL, K., GROSS, P. H., PAMUKCU, R. AND BURT, R. W.: Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase? J. Cell. Biochem. 22: 18-23, 1995.
2. 1 phase of the cell cycle by indomethacin. J. Pharmacol. Exp. Ther. 210: 106-111, 1979.
3. 2 and activation of protein kinase C. J. Biol. Chem. 44: 27258-27263, 1994.
4. DE MELLO, M. C. F., BAYER, B. M. AND BEAVEN, M. A.: Evidence that prosta- glandins do not have a role in the cytostatic antiinflammatory drugs. Biochem. Pharmacol. 29: 311-318, 1980.
5. DOMIN, J. AND ROZENGURT, E.: Heterologous desensitization of platelet-derived growth factor mediated arachidonic acid release and prostaglandin synthesis. J. Biol. Chem. 267: 15217-15223, 1992.
6. DOMIN, J. AND ROZENGURT, E.: Platelet-derived growth factor stimulates a biphasic mobilization of arachidonic acid in Swiss 3T3 cells. J. Biol. Chem. 268: 8927-8934, 1993.
7. DRYSDALE, B. E., ZACHARCHUK, C. M. AND SHIN, H. S.: Mechanism of macrophage-mediated cytotoxicity: Production of a soluble cytotoxic factor. J. Immunol. 131: 2362-2367, 1983.
8. GIARDELLO, F., HAMILTON, S. R., KRUSH, A. J., PIANTADOSI, S., HYLIND, L. M., CELANO, P., BOOKER, S. V., ROBINSON, C. R. AND OFFERHAUS, J. A.: Treatment of colonic and rectal ademomas with sulindac in familiar adenomatous polyposis. N. Engl. J. Med. 328: 1313-1316, 1993.
9. GIL, J., HIGGINS, T. AND ROZENGURT, E.: Mastoparan, a novel mitogen for Swiss 3T3 cells, stimulates pertussis toxin-sensitive arachidonic acid release without inositol phosphate accumulation. J. Cell Biol. 113: 943-950, 1991.
10. GIOVANNUCCI, E., EGAN, K. M., HUNTER, D. J., STAMPFER, M. J., COLDITZ, G. A., WILLETT, W. C. AND SPEIZER, F. E.: Aspirin and the risk of colorectal cancer in women. N. Engl. J. Med. 333: 609-614, 1995.
11. GREENBERG, E. R., BARON, J. A., FREEMAN, D. H., MANDEL, J. S. AND HAILE, R.: Reduced risk of large-bowel adenomas among aspirin users. J. Natl. Cancer Inst. 85: 912-915, 1993.
12. HABENICHT, A. J. R., GOERIG, M., GRULICH, J., ROTHE, D., GRONWALD, R., LOTH, U., SCHETTLER, G., KOMMERELL, B. AND Ross, R.: Human platelet-derived growth factor stimulates prostaglandin synthesis by activation and by rapid de novo synthesis of cyclooxygenase. J. Clin. Invest. 75: 1381-1387, 1985.
13. HALUSHKA, P. V., MAIS, D. E., MAYEUX, P. R. AND MORTINELLI, T. A.: Thromboxane, prostaglandin and leukotriene receptors. Annu. Rev. Pharmacol. Toxicol. 10: 213-239, 1989.
14. HIAL, V., DE MELLO, M. C. F., HORAKOVA, Z. AND BEAVEN, M. A.: Antiproliferative activity of anti-inflammatory drugs in two mammalian cell culture lines. J. Pharmacol. Exp. Ther. 202: 446-454, 1977.
15. HONN, V. K., BOCKMAN, R. S. AND MARNETT, L. J.: Prostaglandins and cancer: a review of tumor initiation through tumor metastasis. Prostaglandins 21: 833-864, 1981.
16. KB by sodium salicylate and aspirin. Science 265: 956-959, 1994.
17. KUJUBU, D. A., FLETCHER, B. S., VARNUM, B. C., LIM, R. W. AND HERSCHMAN, H. R.: TIS10, a phorbol ester tumor promoter-inducible mRNA from mRNA Swiss 3T3 cells, encodes a novel prostaglandin synthuse/cydooxygenasu homologue. J. Biol. Chem. 266: 12866-12872, 1991.
18. KUJUBU, D. A., REDDY, S. T., FLETCHER, B. S. AND HERSCHMAN, H. R.: Expression of the protein product of the prostaglandin synthase-2/TIS10 gene in mitogen-stimulated Swiss 3T3 cells. J. Biol. Chem. 268: 5425-5430, 1993.
19. LANAS, A., HAGERTY, P. AND HIRSCHOWITZ, B. I.: Ingestion of aspirin prevents platelet-induced human fibroblast growth. Scand. J. Gastroenterol. 29: 17-22, 1994.
20. 2 synthesis. Nature Struct. Biol. 2: 637-643, 1995.
21. LU, X., XIE, W., REED, D., BRADSHAW, W. S. AND SIMMONS, D.: Nonsteroidal antiinflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 92: 7961-7965, 1995.
22. LUPULESCU, A.: Enhancement of carcinogenesis by prostaglandins. Nature 272: 634-636, 1978.
23. MALARKEY, K., BELHAM, C. M., PAUL, A., GRAHAM, A., McLESS, A., SCOTT, P. H. AND PLEVIN, R.: The regulation of tyrosine kinase signalling pathaways by growth factor and G-protein-coupled receptors. Biochem. J. 309: 361-375, 1995.
24. MARNETT, L. J.: Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res. 52: 5575-5589, 1992.
25. 2-mediated cyclic AMP accumulation. Exp. Cell Res. 90: 265-270, 1990.
26. MILLAR, J. B. AND ROZENGURT, E.: Bombesin enhancement of cAMP accumulation in Swiss 3T3 cells: Evidence of a dual mechanism of action. J. Cell. Physiol. 137: 214-222, 1988.
27. MILLAR, J. B. AND ROZENGURT, E.: Arachidonic acid release by bombesin. A novel postreceptor target for heterologous mitogenic desensitization. J. Biol. Chem. 265: 19973-19979, 1990.
28. 2α to regulate initiation of DNA replication and cell division in Swiss 3T3 cells. Proc. Natl. Acad. Sci. U.S.A. 79: 4992-4996, 1982.
29. PIAZZA, G. A., KLULCHAK, A. L., KRUTZSCH, M., SPERL, G., PARANKA, N. S., GROSS, P. H., BRENDEL, K., BURT, R. W., ALBERTS, D. S., PAMUKCU, R. AND AHNEN, D. J.: Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res. 55: 3110-3116, 1995.
30. PIOMELLI, D.: Arachidonic acid in cell signalling. Curr. Opin. Cell Biol. 5: 274-280, 1993.
31. REDDY, B. S., TOKUMO, K., KULKARNI, N., ALIGIA, C. AND KELLOFF, G.: Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds. Carcinogenesis 13: 1019-1023, 1992.
32. REDDY, S. T. AND HERSCHMAN, H. R.: Ligand-induced prostaglandin synthesis requires expression of the TIS10/PGS-2 prostaglandin synthase gene in murine fibroblast and macrophages. J. Biol. Chem. 269: 15473-80, 1994.
33. ROSENBERG, L., PALMER, J. R., ZAUBER, A. G., WARSHAUER, M. E., STOLLEY, P. D. AND SHAPIRO, S.: A hipothesis: Nonsteriodal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J. Natl. Cancer Inst. 83: 355-358, 1991.
34. ROZENGURT, E., STROOBANT, P., WATERFIELD, M. D., DEUEL, T. F. AND KEEHAN, M.: Platelet-derived growth factor elicits: Cyclic AMP accumulation in Swiss 3T3 cells: Role of prostaglandin production. Cell 34: 265-272, 1983.
35. ROZENGURT, E.: Early signals in the mitogenic response. Science 234: 161-166, 1986.
36. ras activity. Cancer Cells 3: 397-398, 1991.
37. SHIFF, S. J., QIAO, L., TSAI, L. L. AND RIGAS, B.: Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J. Clin. Invest. 96: 491-503, 1995.
38. SMITH, W.: The eicosanoids and their biochemical mechanism of action. Bio- chem. J. 259: 315-324, 1989.
39. THUN, M. J., NAMBOODIRI, M. M. AND HEATH, C. W.: Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med. 325: 1593-1596, 1991.
40. TSUJII, M. AND DUBOIS, R. N.: Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2. Cell 83: 493-501, 1995.
41. VANE, J. R.: Inhibition of prostaglandin synthesis as mechanism of action for aspirin-like drugs. Nature New Biol. 231: 232-235, 1971.
42. VANE, J. R.: Towards a better aspirin. Nature 367: 315-216, 1994.
43. VINDELOV, L. L., CHRISTENSEN, I. J., KEIDING, N., SPANG-THOMSON, M. AND NISSEN, N. I.: Long-term storage of samples for flow cytometric DNA analysis. Cytometry 3: 317-322, 1983.